These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29111099)

  • 21. Percutaneous penetration and metabolism of 2-butoxyethanol.
    Lockley DJ; Howes D; Williams FM
    Arch Toxicol; 2004 Nov; 78(11):617-28. PubMed ID: 15455191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous penetration and absorption of parathion using human and pig skin models in vitro and human skin grafted onto nude mouse skin model in vivo.
    Boudry I; Blanck O; Cruz C; Blanck M; Vallet V; Bazire A; Capt A; Josse D; Lallement G
    J Appl Toxicol; 2008 Jul; 28(5):645-57. PubMed ID: 18041757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in skin mimic systems to predict transdermal permeation.
    Waters LJ
    Curr Pharm Des; 2015; 21(20):2725-32. PubMed ID: 25925123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies.
    Davies DJ; Ward RJ; Heylings JR
    Toxicol In Vitro; 2004 Jun; 18(3):351-8. PubMed ID: 15046783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
    Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermal absorption of mucopolysaccharide polysulfate (heparinoid) in human and minipig.
    Kumokawa T; Hirata K; Sato K; Kano S
    Arzneimittelforschung; 2011; 61(2):85-91. PubMed ID: 21428242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicochemical characterization and percutaneous delivery of 2,3,5,6-tetramethylpyrazine.
    Qi X; Ackermann C; Sun D; Sheng M; Hou H
    Int J Pharm; 2003 Mar; 253(1-2):177-83. PubMed ID: 12593948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal testosterone delivery in castrated Yucatan minipigs: pharmacokinetics and metabolism.
    Xing QF; Lin S; Chien YW
    J Control Release; 1998 Mar; 52(1-2):89-98. PubMed ID: 9685939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous absorption of topical corticosteroids.
    Wester RC; Maibach HI
    Curr Probl Dermatol; 1993; 21():45-60. PubMed ID: 8299376
    [No Abstract]   [Full Text] [Related]  

  • 32. Modest but increased penetration through damaged skin: an overview of the in vivo human model.
    Gattu S; Maibach HI
    Skin Pharmacol Physiol; 2011; 24(1):2-9. PubMed ID: 20588085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simplified approach for estimating skin permeation parameters from in vitro finite dose absorption studies.
    Lehman PA
    J Pharm Sci; 2014 Dec; 103(12):4048-4057. PubMed ID: 25324199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
    Patel N; Jain S; Lin S
    Int J Pharm; 2016 Nov; 513(1-2):393-403. PubMed ID: 27633278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Yucatan micropig skin for use as an in vitro model for skin permeation study.
    Fujii M; Yamanouchi S; Hori N; Iwanaga N; Kawaguchi N; Matsumoto M
    Biol Pharm Bull; 1997 Mar; 20(3):249-54. PubMed ID: 9084881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic and empirical modeling of skin permeation of drugs.
    Yamashita F; Hashida M
    Adv Drug Deliv Rev; 2003 Sep; 55(9):1185-99. PubMed ID: 12954198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of minipigs in dermal safety assessment: an overview.
    Stricker-Krongrad A; Shoemake CR; Liu J; Brocksmith D; Bouchard G
    Cutan Ocul Toxicol; 2017 Jun; 36(2):105-113. PubMed ID: 27161161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations--an overview.
    Simon GA; Maibach HI
    Skin Pharmacol Appl Skin Physiol; 2000; 13(5):229-34. PubMed ID: 10940812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation assessment for in vitro permeabilities through Yucatan micropig skin.
    Takeuchi H; Terasaka S; Sakurai T; Furuya A; Urano H; Sugibayashi K
    Biol Pharm Bull; 2011; 34(4):555-61. PubMed ID: 21467645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro-in vivo percutaneous penetration of the fungicide ortho-phenylphenol.
    Cnubben NH; Elliott GR; Hakkert BC; Meuling WJ; van de Sandt JJ
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):198-208. PubMed ID: 12052004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.